CEACAM8 and breast carcinoma: To test whether M-DCsTNF can recognize breast cancer cells in vivo, GFP+ MDA-MB-231 cells and DCs expressing CD66b-scFv-cherry or CD66b-cherry were injected into the tibial marrow cavity of athymic nude mice on day 1 and 6, respectively.